12/14/2015
Federal Register Notice: FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet 2/18/16,...12/10/2015
Federal Register Notice: FDA is seeking public comment on a proposed information collection involving interviews of pharmaceutical...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Napo Pharmaceuticals’ Fulyzaq is 7,784 days for...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Janssen Pharmaceutica’s Sirturo is 2,213 days f...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Bristol-Myers Squibb’s Eliquis is 3,685 days fo...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Second Sight Medical Products’ Argus II Visual ...12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Bayer Animal Health’s Veraflox is 3,285 days fo...12/19/2014
Federal Register Notice: FDA will hold a public conference 3/18-19/15 entitled “Serious Drug-Induced Liver Injury (DILI): Th...